Lista de obras - Eduard Parellada - Dominio Público Uruguay

18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia.

artículo científico publicado en 2009

A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients

artículo científico publicado en 2011

A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.

artículo científico publicado en 2009

A continuous emotional task activates the left amygdala in healthy volunteers: (18)FDG PET study

artículo científico publicado en 2009

A prospective flexible-dose study of paliperidone palmitate in nonacute but symptomatic patients with schizophrenia previously unsuccessfully treated with oral antipsychotic agents

artículo científico publicado en 2014

ARVCF single marker and haplotypic association with schizophrenia.

artículo científico publicado en 2009

An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study).

artículo científico publicado en 2017

Antipsychotic therapy amongst Cytochrome P450 2D6 poor metabolizers in the clinical practice: A case report

artículo científico publicado en 2017

Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.

artículo científico publicado en 2015

Association of A/G polymorphism in intron 13 of the monoamine oxidase B gene with schizophrenia in a Spanish population

artículo científico publicado en 2008

Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.

artículo científico publicado en 2016

Brain metabolism during hallucination-like auditory stimulation in schizophrenia

artículo científico publicado en 2014

CYP2D63, 4, 5 AND 6 POLYMORPHISMS AND ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY

Cannabis use and age of diagnosis of schizophrenia

Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism

artículo científico publicado en 2005

Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations.

artículo científico publicado en 2011

Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics

artículo científico publicado en 2006

Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.

artículo científico publicado en 2001

Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study

artículo científico publicado en 2013

Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies

artículo científico publicado en 2005

Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.

artículo científico publicado en 2008

Glucose abnormalities in the siblings of people with schizophrenia

artículo científico publicado en 2008

Hypophyseal response to ECT: a higher and faster vasopressin peak

artículo científico publicado en 1993

Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients

artículo científico publicado en 2013

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population

artículo científico publicado en 2008

Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics

artículo científico publicado en 2014

Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes

artículo científico publicado en 2010

Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes

artículo científico publicado en 2009

Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes

artículo científico publicado en 2010

Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study

artículo científico publicado en 2004

Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait

artículo científico publicado en 2006

Manic syndrome associated with efavirenz overdose

artículo científico publicado en 2001

Metabolic syndrome or glucose challenge in first episode of psychosis?

artículo científico publicado en 2016

Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients.

artículo científico publicado en 2017

Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms

artículo científico publicado en 2015

Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells

artículo científico publicado en 2011

Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable

artículo científico publicado en 2005

Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients.

artículo científico publicado en 2008

Plasma levels of oral risperidone during enteral nutrition in a pregnant schizophrenic patient.

artículo científico publicado en 2015

Polimorfismos genéticos en la catecol-O-metiltransferasa y riesgo de esquizofrenia en población española

artículo científico publicado en 2008

Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting and activation SPECT study

artículo científico publicado en 1994

Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a review

artículo científico publicado en 2015

Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM.

artículo científico publicado en 2009

Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis

artículo científico publicado en 2011

Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies.

artículo científico publicado en 2017

Regional cerebral blood flow pattern in normal young and aged volunteers: a 99mTc-HMPAO SPET study

artículo científico publicado en 1996

Role of the cingulate gyrus during the Wisconsin Card Sorting Test: a single photon emission computed tomography study in normal volunteers

artículo científico publicado en 1998

Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disorders.

artículo científico publicado en 2010

Screening for substance use disorders in first-episode psychosis: implications for readmission

artículo científico publicado en 2013

Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients

artículo científico publicado en 2010

Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study

artículo científico publicado en 2003

Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis.

artículo científico publicado en 2009

Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis

artículo científico publicado en 2011

The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients

artículo científico publicado en 1998

Treatment of narcolepsy complicated by psychotic symptoms

artículo científico publicado en 2009

[Probable levetiracetam-induced psychosis]

artículo científico publicado en 2007

[Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone]

artículo científico publicado en 2006

¿Hikikomori o esquizofrenia simple?

artículo científico publicado en 2008

Lista de obras de Eduard Parellada

18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia.

A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients

A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.

A continuous emotional task activates the left amygdala in healthy volunteers: (18)FDG PET study

A prospective flexible-dose study of paliperidone palmitate in nonacute but symptomatic patients with schizophrenia previously unsuccessfully treated with oral antipsychotic agents

ARVCF single marker and haplotypic association with schizophrenia.

An open-treatment six-week study of the clinical effectiveness of Paliperidone Palmitate in schizophrenia: data from acute units in Spain (SHADOW study).

Antipsychotic therapy amongst Cytochrome P450 2D6 poor metabolizers in the clinical practice: A case report

Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.

Association of A/G polymorphism in intron 13 of the monoamine oxidase B gene with schizophrenia in a Spanish population

Barriers to the Use of Long-Acting Injectable Antipsychotics in the Management of Schizophrenia.

Brain metabolism during hallucination-like auditory stimulation in schizophrenia

CYP2D6*3, *4, *5 AND *6 POLYMORPHISMS AND ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY

Cannabis use and age of diagnosis of schizophrenia

Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism

Differential brain glucose metabolic patterns in antipsychotic-naïve first-episode schizophrenia with and without auditory verbal hallucinations.

Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics

Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.

Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study

Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies

Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation.

Glucose abnormalities in the siblings of people with schizophrenia

Hypophyseal response to ECT: a higher and faster vasopressin peak

Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with schizophrenia in a Spanish population

Intramuscular long-acting paliperidone palmitate in acute patients with schizophrenia unsuccessfully treated with oral antipsychotics

Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes

Lack of association between antipsychotic-induced extrapyramidal symptoms and polymorphisms in dopamine metabolism and transport genes

Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes

Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study

Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait

Manic syndrome associated with efavirenz overdose

Metabolic syndrome or glucose challenge in first episode of psychosis?

Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients.

Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms

Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells

Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable

Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients.

Plasma levels of oral risperidone during enteral nutrition in a pregnant schizophrenic patient.

Polimorfismos genéticos en la catecol-O-metiltransferasa y riesgo de esquizofrenia en población española

Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting and activation SPECT study

Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability - a review

Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM.

Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis

Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders: a systematic review of randomized and nonrandomized studies.

Regional cerebral blood flow pattern in normal young and aged volunteers: a 99mTc-HMPAO SPET study

Role of the cingulate gyrus during the Wisconsin Card Sorting Test: a single photon emission computed tomography study in normal volunteers

Safety and efficacy of long-acting injectable risperidone in daily practice: an open-label, noninterventional, prospective study in schizophrenia and related disorders.

Screening for substance use disorders in first-episode psychosis: implications for readmission

Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients

Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study

Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis.

Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis

The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients

Treatment of narcolepsy complicated by psychotic symptoms

[Probable levetiracetam-induced psychosis]

[Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone]

¿Hikikomori o esquizofrenia simple?

CYP2D63, 4, 5 AND 6 POLYMORPHISMS AND ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL SIDE-EFFECTS IN PATIENTS RECEIVING ANTIPSYCHOTIC THERAPY